|
1
|
Li Y, Yang Y, Feng Y, Yan J, Fan C, Jiang
S and Qu Y: A review of melatonin in hepatic ischemia/reperfusion
injury and clinical liver disease. Ann Med. 46:503–511. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu LF, Qin Q, Qian ZH, Shi M, Deng QC,
Zhu WP, Zhang H, Tao XM and Liu Y: Protective effects of melatonin
on ischemia-reperfusion induced myocardial damage and hemodynamic
recovery in rats. Eur Rev Med Pharmacol Sci. 18:3681–3686.
2014.PubMed/NCBI
|
|
3
|
Rodríguez-Reynoso S, Leal C, Portilla E,
Olivares N and Muñiz J: Effect of exogenous melatonin on hepatic
energetic status during ischemia/reperfusion: Possible role of
tumor necrosis factor-α and nitric oxide. J Surg Res. 100:141–149.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deprés-Brummer P, Metzger G, Morin D,
Urien S, Touitou Y, Tillement JP, Claustrat B and Lévi F:
Pharmacokinetically guided melatonin scheduling in rats with
circadian system suppression. Eur J Pharmacol. 312:171–178. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simeoni E, Dudler J, Fleury S, Li J,
Pagnotta M, Pascual M, von Segesser LK and Vassalli G: Gene
transfer of a soluble IL-1 type 2 receptor-Ig fusion protein
improves cardiac allograft survival in rats. Eur J Cardiothorac
Surg. 31:222–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sener G, Sehirli O, Velioğlu-Oğünç A,
Cetinel S, Gedik N, Caner M, Sakarcan A and Yeğen BC: Montelukast
protects against renal ischemia/reperfusion injury in rats.
Pharmacol Res. 54:65–71. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Menger MD, Richter S, Yamauchi J and
Vollmar B: Role of microcirculation in hepatic ischemia/reperfusion
injury. Hepatogastroenterology. 46(Suppl 2): 1452–1457.
1999.PubMed/NCBI
|
|
8
|
Galea J, Armstrong J, Gadsdon P, Holden H,
Francis SE and Holt CM: Interleukin-1 beta in coronary arteries of
patients with ischemic heart disease. Arterioscler Thromb Vasc
Biol. 16:1000–1006. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deten A, Volz HC, Briest W and Zimmer HG:
Cardiac cytokine expression is upregulated in the acute phase after
myocardial infarction. Experimental studies in rats. Cardiovasc
Res. 55:329–340. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herskowitz A, Choi S, Ansari AA and
Wesselingh S: Cytokine mRNA expression in postischemic/reperfused
myocardium. Am J Pathol. 146:419–428. 1995.PubMed/NCBI
|
|
11
|
Neumann FJ, Marx N, Gawaz M, Brand K, Ott
I, Rokitta C, Sticherling C, Meinl C, May A and Schömig A:
Induction of cytokine expression in leukocytes by binding of
thrombin-stimulated platelets. Circulation. 95:2387–2394. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prabhu SD, Chandrasekar B, Murray DR and
Freeman GL: beta-adrenergic blockade in developing heart failure:
Effects on myocardial inflammatory cytokines, nitric oxide, and
remodeling. Circulation. 101:2103–2109. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hashimoto K, Nishizaki T, Yoshizumi T,
Uchiyama H, Okano S, Ikegami T, Yanaga K and Sugimachi K:
Beneficial effect of FR167653 on cold ischemia/reperfusion injury
in rat liver transplantation. Transplantation. 70:1318–1322. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kobayashi J, Takeyoshi I, Ohwada S,
Iwanami K, Matsumoto K, Muramoto M and Morishita Y: The effects of
FR167653 in extended liver resection with ischemia in dogs.
Hepatology. 28:459–465. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harada H, Wakabayashi G, Takayanagi A,
Shimazu M, Matsumoto K, Obara H, Shimizu N and Kitajima M: Transfer
of the interleukin-1 receptor antagonist gene into rat liver
abrogates hepatic ischemia-reperfusion injury. Transplantation.
74:1434–1441. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki K, Murtuza B, Smolenski R, Sammut
IA, Suzuki N, Kaneda Y and Yacoub MH: Overexpression of
interleukin-1 receptor antagonist provides cardio protection
against ischemia-reperfusion injury associated with reduction in
apoptosis. Circulation. 104(Suppl 1): 308–313. 2001.
|
|
17
|
Maedler K, Sergeev P, Ehses JA, Mathe Z,
Bosco D, Berney T, Dayer JM, Reinecke M, Halban PA and Donath MY:
Leptin modulates beta cell expression of IL-1 receptor antagonist
and release of IL-1beta in human islets. Proc Natl Acad Sci USA.
101:8138–8143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kohli V, Gao W, Camargo CA Jr and Clavien
PA: Calpain is a mediator of preservation-reperfusion injury in rat
liver transplantation. Proc Natl Acad Sci USA. 94:9354–9359. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li SQ, Liang LJ, Huang JF and Li Z:
Ischemic preconditioning protects liver from hepatectomy under
hepatic inflow occlusion for hepatocellular carcinoma patients with
cirrhosis. World J Gastroenterol. 10:2580–2584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hur GM, Ryu YS, Yun HY, Jeon BH, Kim YM,
Seok JH and Lee JH: Hepatic ischemia/reperfusion in rats induces
iNOS gene transcription by activation of NF-kappaB. Biochem Biophys
Res Commun. 261:917–922. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiong S, She H, Takeuchi H, Han B,
Engelhardt JF, Barton CH, Zandi E, Giulivi C and Tsukamoto H:
Signaling role of intracellular iron in NF-kappaB activation. J
Biol Chem. 278:17646–17654. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koeppel TA, Thies JC, Schemmer P, Trauner
M, Gebhard MM, Otto G and Post S: Inhibition of nitric oxide
synthesis in ischemia/reperfusion of the rat liver is followed by
impairment of hepatic microvascular blood flow. J Hepatol.
27:163–169. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Raz R, Durbin JE and Levy DE: Acute phase
response factor and additional members of the interferon-stimulated
gene factor 3 family integrate diverse signals from cytokines,
interferons, and growth factors. J Biol Chem. 269:24391–24395.
1994.PubMed/NCBI
|
|
24
|
Gabay C, Smith MF, Eidlen D and Arend WP:
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase
protein. J Clin Invest. 99:2930–2940. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pang SF, Dubocovich ML and Brown GM:
Melatonin receptors in peripheral tissues: A new area of melatonin
research. Biol Signals. 2:177–180. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ding WH, Wu FX and Li DY: The change of
plasma interleukin-6 level and cardiac protective effect of
monoclonal antibody to IL-6 during myocardial infarction. Zhonghua
Xin Xue Guan Bing Za Zhi. 27:29–32. 1999.(In Chinese).
|
|
27
|
Barrier A, Olaya N, Chiappini F, Roser F,
Scatton O, Artus C, Franc B, Dudoit S, Flahault A, Debuire B, et
al: Ischemic preconditioning modulates the expression of several
genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in
a human model of liver ischemia-reperfusion. FASEB J. 19:1617–1626.
2005. View Article : Google Scholar : PubMed/NCBI
|
